Skip to content
cancer.gov logo

Welcome About caBIG News SiteMap Contact Us Help
  You are not logged in Participant Log In
You are here: Home » For Vendors

For Vendors

NCI welcomes involvement of commercial groups in the caBIG pilot initiative. To date, many commercial organizations and some not-for-profit organizations have participated in caBIG activities on a voluntary basis or met with National Cancer Institute (NCI) representatives to discuss their interest in the caBIG initiative. These organizations include information technology companies, large-scale software vendors, pharmaceutical companies, and biotech companies as well as small, specialized ventures. Participation varies from occasional involvement in open meetings to regular involvement with specific caBIG Workspace and Working Group activities. Some commercial groups with particular expertise in specific caBIG Workspaces are participating as unfunded Working Group members.

At this stage, commercial organizations are welcome to participate on a voluntary basis. There is currently no direct funding for commercial organizations to undertake caBIG pilot project activities, as the primary participants of the caBIG pilot are NCI-designated Cancer Centers. Opportunities for more directly funded involvement in caBIG project activities may emerge at a later date as the caBIG effort progresses.

Please watch this site for additional information on the ways commercial organizations can participate in the caBIG initiative. Current information that is of interest includes:

  • caBIG Compatibility Guidelines: The purpose of this document is to provide guidelines for caBIG participants and interested stakeholders on caBIG compatibility. This document provides a set of definitions that caBIG participants can use to measure the maturity level of potential caBIG applications.
  • caGRID Whitepaper: This document provides an overview of the prototype for the emerging grid infrastructure for the caBIG initiative.
If you have any additional questions, please feel free to contact Mark Adams, PhD.
« October 2004 »
Su Mo Tu We Th Fr Sa
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31            
2004-10-07
12:00:00-13:00:00 Clinical Trial Management Systems: Lab Interfaces SIG
13:00:00-14:00:00 Vocabularies and Common Data Elements
15:00:00-16:00:00 Integrative Cancer Research: Gene Annotation SIG
2004-10-11
14:00:00-15:00:00 Integrative Cancer Research
2004-10-12
12:00:00-13:00:00 Clinical Trial Management Systems
2004-10-13
12:00:00-13:00:00 Clinical Trial Management Systems: CDUS Reporting SIG
2004-10-14
10:00:00-11:00:00 Clinical Trial Management Systems: Financial/Billing SIG
14:00:00-15:00:00 Data Sharing and Intellectual Capital
2004-10-15
15:00:00-16:00:00 Clinical Trial Management Systems: Adverse Events SIG
2004-10-18
14:00:00-15:00:00 Integrative Cancer Research: Informatics for Proteomics SIG
2004-10-19
12:00:00-13:00:00 Tissue Banks and Pathology Tools
2004-10-21
12:00:00-13:00:00 Clinical Trial Management Systems: Lab Interfaces SIG
13:00:00-14:00:00 Vocabularies and Common Data Elements
2004-10-25
08:00:00 - Architecture and Vocabularies & Common Data Elements Face-to-Face
2004-10-26
Architecture and Vocabularies & Common Data Elements Face-to-Face - 17:00:00
12:00:00-13:00:00 Clinical Trial Management Systems
2004-10-27
12:00:00-13:00:00 Clinical Trial Management Systems: CDUS Reporting SIG
2004-10-28
10:00:00-11:00:00 Clinical Trial Management Systems: Financial/Billing SIG
14:00:00-15:00:00 Data Sharing and Intellectual Capital